Atlas Trials

Early add-on Vildagliptin in Patients With Type 2 Diabetes Inadequately Controlled by Metformin

Clinical trial NCT01766778 · COMPLETED

Trial details

NCT number
NCT01766778
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Type-2 Diabetes Mellitus
Start date
2013-05-13
Primary completion
2015-10-22
Enrollment
117

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.